Scherzer, T M <br/><br/>
Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Sep 2008 
 - 742-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2008.03779.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Comorbidity<br/>Crohn Disease--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus--isolation & purification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Immunocompromised Host--immunology<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Polymerase Chain Reaction<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Treatment Outcome